School of Basic Medical Sciences, Wuhan University, Wuhan, China.
Hubei Key Laboratory of Cell Homeostasis, College of Life Sciences, Wuhan University, Wuhan, China.
Hepatology. 2019 Mar;69(3):974-992. doi: 10.1002/hep.30248.
Hepatitis B virus (HBV) is a major risk factor for the development and progression of hepatocellular carcinoma. It has been reported that viral infection can interfere with cellular microRNA (miRNA) expression and participate in the pathogenesis of oncogenicity. Here, we report that decreasing levels of the expression of the miRNA miR-192-3p is associated with rising levels of HBV DNA in the serum of HBV patients. We revealed that HBV infection repressed the expression of miR-192-3p through hepatitis B x protein interaction with c-myc. We further showed that miR-192-3p was repressed by HBV transfection in vitro and in a mouse model, leading to cellular autophagy. Using an miRNA target prediction database miRBase, we identified X-linked inhibitor of apoptosis protein (XIAP) as a target gene of miR-192-3p and demonstrated that miR-192-3p directly targeted the XIAP 3'-untranslated region of XIAP messenger RNA. Importantly, we discovered that HBV promoted autophagy through miR-192-3p-XIAP axis and that this process was important for HBV replication in vitro and in vivo. We demonstrated that miR-192-3p functioned through the nuclear factor kappa B signaling pathway to inhibit autophagy, thereby reducing HBV replication. Conclusions: Our findings indicate that miR-192-3p is a regulator of HBV infection and may play a potential role in hepatocellular carcinoma. It may also serve as a biomarker or therapeutic target for HBV patients.
乙型肝炎病毒(HBV)是肝细胞癌发生和发展的主要危险因素。据报道,病毒感染可以干扰细胞微小 RNA(miRNA)的表达,并参与致癌作用的发病机制。在这里,我们报告说,miR-192-3p 的表达水平降低与 HBV 患者血清中 HBV DNA 水平升高有关。我们揭示了 HBV 感染通过乙型肝炎 x 蛋白与 c-myc 的相互作用抑制 miR-192-3p 的表达。我们进一步表明,miR-192-3p 在体外和小鼠模型中被 HBV 转染抑制,导致细胞自噬。使用 miRNA 靶标预测数据库 miRBase,我们鉴定出 X 连锁凋亡抑制蛋白(XIAP)是 miR-192-3p 的靶基因,并证明 miR-192-3p 直接靶向 XIAP 信使 RNA 的 XIAP 3'-非翻译区。重要的是,我们发现 HBV 通过 miR-192-3p-XIAP 轴促进自噬,并且该过程对于 HBV 在体外和体内的复制很重要。我们证明 miR-192-3p 通过核因子 kappa B 信号通路发挥作用,抑制自噬,从而减少 HBV 复制。结论:我们的研究结果表明,miR-192-3p 是 HBV 感染的调节剂,可能在肝细胞癌中发挥潜在作用。它也可能作为 HBV 患者的生物标志物或治疗靶点。